Hemodynamic consequences of premature ventricular contractions: Association of mechanical bradycardia and postextrasystolic potentiation with premature ventricular contraction-induced cardiomyopathy

Heart Rhythm. 2019 Jun;16(6):853-860. doi: 10.1016/j.hrthm.2018.12.008. Epub 2018 Dec 11.

Abstract

Background: The relationships between hemodynamic consequences of premature ventricular contractions (PVCs) and development of premature ventricular contraction-induced cardiomyopathy (PVC-CM) have not been investigated.

Objective: The purpose of this study was to correlate concealed mechanical bradycardia and/or postextrasystolic potentiation (PEP) to PVC-CM.

Methods: Invasive arterial pressure measurements from 17 patients with PVC-CM and 16 controls with frequent PVCs were retrospectively analyzed. PVCs were considered efficient (ejecting PVCs) when generating a measurable systolic arterial pressure. PEP was defined by a systolic arterial pressure of the post-PVC beat ≥5 mm Hg higher than the preceding sinus beat. Every PVC was analyzed for 10 minutes before ablation, and the electromechanical index (EMi = number of ejecting PVCs/total PVC) and postextrasystolic potentiation index (PEPi = number of PVCs with PEP/total PVC) were calculated.

Results: EMi was 29% ± 31% in PVC-CM and 78% ± 20% in controls (P <.0001). PEPi was 41% ± 28% in PVC-CM and 14% ± 10% in controls (P = .001). There was no control in groups of low EMi or high PEPi. EMi and PEPi were not significantly correlated to left ventricular dimensions or function in PVC-CM patients. PVC coupling interval was related to both ejecting PVCs and PEP.

Conclusion: Patients with PVC-CM more often display nonejecting PVCs and PEP compared to controls.

Keywords: Ablation; Cardiomyopathy; Mechanical bradycardia; Postextrasystolic potentiation; Premature ventricular contraction.

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use
  • Arterial Pressure*
  • Blood Pressure
  • Blood Pressure Determination / methods
  • Bradycardia* / diagnosis
  • Bradycardia* / physiopathology
  • Cardiac Electrophysiology
  • Cardiomyopathies* / diagnosis
  • Cardiomyopathies* / etiology
  • Cardiomyopathies* / physiopathology
  • Correlation of Data
  • Echocardiography / methods
  • Electrophysiologic Techniques, Cardiac / methods
  • Female
  • Heart Ventricles* / pathology
  • Heart Ventricles* / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Organ Size
  • Ventricular Premature Complexes* / complications
  • Ventricular Premature Complexes* / diagnosis
  • Ventricular Premature Complexes* / drug therapy
  • Ventricular Premature Complexes* / physiopathology

Substances

  • Anti-Arrhythmia Agents